Ritanserin has been used in trials studying the treatment of Cocaine-Related Disorders.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Cyproheptadine | The therapeutic efficacy of Ritanserin can be decreased when used in combination with Cyproheptadine. |
| Desmopressin | The risk or severity of hyponatremia can be increased when Ritanserin is combined with Desmopressin. |
| Ioflupane I-123 | Ritanserin may decrease effectiveness of Ioflupane I-123 as a diagnostic agent. |
| Linezolid | The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Ritanserin. |
| Metyrosine | The risk or severity of extrapyramidal symptoms can be increased when Metyrosine is combined with Ritanserin. |
| Pimozide | The risk or severity of QTc prolongation can be increased when Ritanserin is combined with Pimozide. |
| Buprenorphine | Ritanserin may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine. |
| Doxylamine | Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Ritanserin. |
| Dronabinol | Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Ritanserin. |
| Droperidol | Droperidol may increase the central nervous system depressant (CNS depressant) activities of Ritanserin. |
| Hydrocodone | Ritanserin may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone. |
| Hydroxyzine | Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Ritanserin. |
| Magnesium sulfate | The therapeutic efficacy of Ritanserin can be increased when used in combination with Magnesium sulfate. |
| Methotrimeprazine | Ritanserin may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine. |
| Minocycline | Minocycline may increase the central nervous system depressant (CNS depressant) activities of Ritanserin. |
| Nabilone | Nabilone may increase the central nervous system depressant (CNS depressant) activities of Ritanserin. |
| Orphenadrine | Ritanserin may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine. |
| Paraldehyde | Ritanserin may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde. |
| Perampanel | Perampanel may increase the central nervous system depressant (CNS depressant) activities of Ritanserin. |
| Pramipexole | Ritanserin may increase the sedative activities of Pramipexole. |
| Ropinirole | Ritanserin may increase the sedative activities of Ropinirole. |
| Rotigotine | Ritanserin may increase the sedative activities of Rotigotine. |
| Rufinamide | The risk or severity of adverse effects can be increased when Rufinamide is combined with Ritanserin. |
| Sodium oxybate | Ritanserin may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Suvorexant | Ritanserin may increase the central nervous system depressant (CNS depressant) activities of Suvorexant. |
| Tapentadol | Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Ritanserin. |
| Thalidomide | Ritanserin may increase the central nervous system depressant (CNS depressant) activities of Thalidomide. |
| Zolpidem | Ritanserin may increase the central nervous system depressant (CNS depressant) activities of Zolpidem. |
| Yohimbine | The therapeutic efficacy of Ritanserin can be increased when used in combination with Yohimbine. |
| Brexpiprazole | The metabolism of Brexpiprazole can be decreased when combined with Ritanserin. |
| Eliglustat | The metabolism of Eliglustat can be decreased when combined with Ritanserin. |
| Amisulpride | Ritanserin may increase the antipsychotic activities of Amisulpride. |
| Methylphenidate | The risk or severity of adverse effects can be increased when Ritanserin is combined with Methylphenidate. |
| Metoclopramide | The risk or severity of adverse effects can be increased when Metoclopramide is combined with Ritanserin. |
| Quinagolide | The therapeutic efficacy of Quinagolide can be decreased when used in combination with Ritanserin. |
| Sulpiride | Ritanserin may increase the antipsychotic activities of Sulpiride. |
| Methadone | The risk or severity of adverse effects can be increased when Methadone is combined with Ritanserin. |
| Mequitazine | Ritanserin may increase the arrhythmogenic activities of Mequitazine. |
| Atomoxetine | The metabolism of Atomoxetine can be decreased when combined with Ritanserin. |
| Tedizolid phosphate | The risk or severity of serotonin syndrome can be increased when Tedizolid phosphate is combined with Ritanserin. |
| Mirtazapine | Ritanserin may increase the serotonergic activities of Mirtazapine. |
| Morphine | The risk or severity of serotonin syndrome can be increased when Morphine is combined with Ritanserin. |
| Codeine | The risk or severity of serotonin syndrome can be increased when Codeine is combined with Ritanserin. |
| Hydromorphone | The risk or severity of serotonin syndrome can be increased when Hydromorphone is combined with Ritanserin. |
| Oxycodone | The risk or severity of serotonin syndrome can be increased when Oxycodone is combined with Ritanserin. |
| Butorphanol | The risk or severity of serotonin syndrome can be increased when Butorphanol is combined with Ritanserin. |
| Dextropropoxyphene | The risk or severity of serotonin syndrome can be increased when Dextropropoxyphene is combined with Ritanserin. |
| Pentazocine | The risk or severity of serotonin syndrome can be increased when Pentazocine is combined with Ritanserin. |
| Sufentanil | The risk or severity of serotonin syndrome can be increased when Sufentanil is combined with Ritanserin. |
| Alfentanil | The risk or severity of serotonin syndrome can be increased when Alfentanil is combined with Ritanserin. |
| Fentanyl | The risk or severity of serotonin syndrome can be increased when Fentanyl is combined with Ritanserin. |
| Nalbuphine | The risk or severity of serotonin syndrome can be increased when Nalbuphine is combined with Ritanserin. |
| Levorphanol | The risk or severity of serotonin syndrome can be increased when Levorphanol is combined with Ritanserin. |
| Remifentanil | The risk or severity of serotonin syndrome can be increased when Remifentanil is combined with Ritanserin. |
| Diphenoxylate | The risk or severity of serotonin syndrome can be increased when Diphenoxylate is combined with Ritanserin. |
| Oxymorphone | The risk or severity of serotonin syndrome can be increased when Oxymorphone is combined with Ritanserin. |
| Dezocine | The risk or severity of serotonin syndrome can be increased when Dezocine is combined with Ritanserin. |
| Levacetylmethadol | The risk or severity of serotonin syndrome can be increased when Levacetylmethadol is combined with Ritanserin. |
| Methadyl acetate | The risk or severity of serotonin syndrome can be increased when Methadyl acetate is combined with Ritanserin. |
| Dihydroetorphine | The risk or severity of serotonin syndrome can be increased when Dihydroetorphine is combined with Ritanserin. |
| Diamorphine | The risk or severity of serotonin syndrome can be increased when Diamorphine is combined with Ritanserin. |
| Ethylmorphine | The risk or severity of serotonin syndrome can be increased when Ethylmorphine is combined with Ritanserin. |
| Etorphine | The risk or severity of serotonin syndrome can be increased when Etorphine is combined with Ritanserin. |
| Dextromoramide | The risk or severity of serotonin syndrome can be increased when Dextromoramide is combined with Ritanserin. |
| Desomorphine | The risk or severity of serotonin syndrome can be increased when Desomorphine is combined with Ritanserin. |
| Carfentanil | The risk or severity of serotonin syndrome can be increased when Carfentanil is combined with Ritanserin. |
| Dihydrocodeine | The risk or severity of serotonin syndrome can be increased when Dihydrocodeine is combined with Ritanserin. |
| Alphacetylmethadol | The risk or severity of serotonin syndrome can be increased when Alphacetylmethadol is combined with Ritanserin. |
| Dihydromorphine | The risk or severity of serotonin syndrome can be increased when Dihydromorphine is combined with Ritanserin. |
| Ketobemidone | The risk or severity of serotonin syndrome can be increased when Ketobemidone is combined with Ritanserin. |
| DPDPE | The risk or severity of serotonin syndrome can be increased when DPDPE is combined with Ritanserin. |
| Lofentanil | The risk or severity of serotonin syndrome can be increased when Lofentanil is combined with Ritanserin. |
| Opium | The risk or severity of serotonin syndrome can be increased when Opium is combined with Ritanserin. |
| Normethadone | The risk or severity of serotonin syndrome can be increased when Normethadone is combined with Ritanserin. |
| Piritramide | The risk or severity of serotonin syndrome can be increased when Piritramide is combined with Ritanserin. |
| Alphaprodine | The risk or severity of serotonin syndrome can be increased when Alphaprodine is combined with Ritanserin. |
| Meptazinol | The risk or severity of serotonin syndrome can be increased when Meptazinol is combined with Ritanserin. |
| Phenoperidine | The risk or severity of serotonin syndrome can be increased when Phenoperidine is combined with Ritanserin. |
| Phenazocine | The risk or severity of serotonin syndrome can be increased when Phenazocine is combined with Ritanserin. |
| Tilidine | The risk or severity of serotonin syndrome can be increased when Tilidine is combined with Ritanserin. |
| Carfentanil, C-11 | The risk or severity of serotonin syndrome can be increased when Carfentanil, C-11 is combined with Ritanserin. |
| Naltrexone | The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Ritanserin. |
| Bezitramide | The risk or severity of serotonin syndrome can be increased when Bezitramide is combined with Ritanserin. |
| Eluxadoline | The risk or severity of serotonin syndrome can be increased when Eluxadoline is combined with Ritanserin. |
| Nicomorphine | The risk or severity of serotonin syndrome can be increased when Nicomorphine is combined with Ritanserin. |
| Meperidine | The risk or severity of serotonin syndrome can be increased when Meperidine is combined with Ritanserin. |
| Benzhydrocodone | The risk or severity of serotonin syndrome can be increased when Benzhydrocodone is combined with Ritanserin. |
| Naloxegol | The risk or severity of serotonin syndrome can be increased when Naloxegol is combined with Ritanserin. |
| Iobenguane | Ritanserin may decrease effectiveness of Iobenguane as a diagnostic agent. |
| Methyclothiazide | The risk or severity of hyponatremia can be increased when Ritanserin is combined with Methyclothiazide. |
| Chlorthalidone | The risk or severity of hyponatremia can be increased when Ritanserin is combined with Chlorthalidone. |
| Bendroflumethiazide | The risk or severity of hyponatremia can be increased when Ritanserin is combined with Bendroflumethiazide. |
| Metolazone | The risk or severity of hyponatremia can be increased when Ritanserin is combined with Metolazone. |
| Benzthiazide | The risk or severity of hyponatremia can be increased when Ritanserin is combined with Benzthiazide. |
| Hydroflumethiazide | The risk or severity of hyponatremia can be increased when Ritanserin is combined with Hydroflumethiazide. |
| Indapamide | The risk or severity of hyponatremia can be increased when Ritanserin is combined with Indapamide. |
| Chlorothiazide | The risk or severity of hyponatremia can be increased when Ritanserin is combined with Chlorothiazide. |
| Hydrochlorothiazide | The risk or severity of hyponatremia can be increased when Ritanserin is combined with Hydrochlorothiazide. |
| Trichlormethiazide | The risk or severity of hyponatremia can be increased when Ritanserin is combined with Trichlormethiazide. |
| Polythiazide | The risk or severity of hyponatremia can be increased when Ritanserin is combined with Polythiazide. |